The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JCEM.87.1.8135PMID 11788670
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA isolation by a rapid method from human blood samples: Effects of MgCl2, EDTA, storage time, and temperature on DNA yield and quality

  2004cited by this paper
• The short-term changes of bone mineral metabolism following bone marrow transplantation.

  2000cited by this paper
• Age‐Related Osteogenic Potential of Mesenchymal Stromal Stem Cells from Human Vertebral Bone Marrow

  1999cited by this paper
• Regulation of osteogenic differentiation of human bone marrow stromal cells: interaction between transforming growth factor-beta and 1,25(OH)(2) vitamin D(3) In vitro.

  1999cited by this paper
• Mechanisms of Bone Loss Following Allogeneic and Autologous Hemopoietic Stem Cell Transplantation

  1999cited by this paper
• Regulation of Osteogenic Differentiation of Human Bone Marrow Stromal Cells: Interaction Between Transforming Growth Factor-β and 1,25(OH)2 Vitamin D3In Vitro

  1999cited by this paper
• Thyroid hormone excess increases insulin-like growth factor I transcripts in bone marrow cell cultures: divergent effects on vertebral and femoral cell cultures.

  1998cited by this paper
• Bone loss and turnover after cardiac transplantation.

  1997cited by this paper
• Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation

  1997cited by this paper
• Isolation and characterization of osteoblast precursor cells from human bone marrow

  1996cited by this paper
• Bone density loss during treatment of chronic GVHD.

  1996cited by this paper
• Bone mineral density after kidney transplantation. A cross-sectional study in 190 graft recipients up to 20 years after transplantation.

  1995cited by this paper
• Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone.

  1994cited by this paper
• Acute effects of high-dose chemotherapy followed by bone marrow transplantation on serum markers of bone metabolism

  1994cited by this paper
• Osteoporosis and bone morbidity in cardiac transplant recipients.

  1994cited by this paper
• Evaluation of mixed chimaerism and origin of bone marrow derived fibroblastoid cells after allogeneic bone marrow transplantation

  1994cited by this paper
• Bone morphology after bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma.

  1993cited by this paper
• DNA isolation by a rapid method from human blood samples: Effects of MgCl2, EDTA, storage time, and temperature on DNA yield and quality

  1993cited by this paper
• Host origin of bone marrow fibroblasts following allogeneic bone marrow transplantation for chronic myeloid leukemia.

  1992cited by this paper
• Bone disease after liver transplantation.

  1992cited by this paper
• Posttransplantation bone disease.

  1992cited by this paper
• Recipient origin of bone marrow‐derived fibroblastic stromal cells during all periods following bone marrow transplantation in humans

  1991cited by this paper
• Reduced bone mineral density in men and women with allogeneic bone marrow transplantation.

  1990cited by this paper
• Hematopoietic microenvironment. Origin, lineage, and transplantability of the stromal cells in long-term bone marrow cultures from chimeric mice.

  1988cited by this paper
• Measurement of protein using bicinchoninic acid.

  1985cited by this paper
• Bone cell phosphotyrosine phosphatase: characterization and regulation by calcitropic hormones.

  1985cited by this paper
• Donor origin of the in vitro hematopoietic microenvironment after marrow transplantation in mice

  1984cited by this paper
• Hemopoietic stromal microenvironment

  1983cited by this paper
• Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man

  1982cited by this paper

• Micronutrient requirements for stem cell transplantation patients > 100 days after transplant and during graft versus host disease: a systematic review

  2025cites this paper
• Characterization and Predictors of Fractures following Hematopoietic Stem Cell Transplantation.

  2024cites this paper
• Short-Term Impact of Hematopoietic Stem Cell Transplantation in Leukemia Patients on Bone Bio Markers, Electrolytes and Blood Profile

  2023cites this paper
• Endocrine sequelae of hematopoietic stem cell transplantation: Effects on mineral homeostasis and bone metabolism

  2023cites this paper
• Bone Health and Cancer Therapy

  2022cites this paper
• A Systematic Review of the Evidence of Hematopoietic Stem Cell Differentiation to Fibroblasts

  2022cites this paper
• Chondrodysplasia and growth failure in children after early hematopoietic stem cell transplantation for non‐oncologic disorders

  2021cites this paper
• Changes in Serum Dickkopf-1, RANK Ligand, Osteoprotegerin, and Bone Mineral Density after Allogeneic Hematopoietic Stem Cell Transplantation Treatment

  2021cites this paper
• Relationship between endocrine changes and bone markers in pediatric thalassemic patients after hematopoietic stem cell transplantation

  2021cites this paper
• Osteoporosis in organ transplant patients

  2021cites this paper
• Secondary Osteoporosis.

  2021cites this paper
• Vitamin D Deficiency, Osteoporosis and Effect on Autoimmune Diseases and Hematopoiesis: A Review

  2021cites this paper
• Risk factors for haematopoietic stem cell transplant (HSCT) associated bone loss: bone marrow transplantation associated bone loss.

  2020cites this paper
• Effect of Denosumab on Bone Mineral Density of Hematopoietic Stem Cell Transplantation Recipients

  2020cites this paper
• Effects of Hormone Replacement Therapy on Bone Mass after Allogeneic Hematopoietic Stem Cell Transplantation.

  2020cites this paper
• Transplantation Osteoporosis

  2020cites this paper
• Metcalf Lecture Award Manuscript-Applying niche biology to engineer T cell regenerative therapies.

  2019cites this paper
• Changes in trabecular bone score and bone mineral density following allogeneic hematopoietic stem cell transplantation.

  2019cites this paper
• Transplantation osteoporosis

  2018cites this paper
• Relative Chemo-, Hormonal, and Immunosensitivity

  2018cites this paper
• Allogeneic yet major histocompatibility complex-matched bone marrow transplantation in mice results in an impairment of osteoblasts and a significantly reduced trabecular bone

  2017cites this paper
• Osteoporosis in Organ Transplant Patients

  2016cites this paper
• Aging alters bone-fat reciprocity by shifting in vivo mesenchymal precursor cell fate towards an adipogenic lineage.

  2016cites this paper
• How is the relation between endocrine changes and bone markers in pediatric thalassemic patients after Hematopoietic Stem Cell Transplantation.

  2016cites this paper
• Early changes in bone mineral density and trabecular bone score following allogeneic stem cell transplant

  2016cites this paper
• Osteogenic Effects of Pigment Epithelium Derived Factor on Mesenchymal Stem Cells

  2015cites this paper
• Impact of Radiation on Hematopoietic Niche

  2015cites this paper
• Myelosuppressive Therapies Significantly Increase Pro‐Inflammatory Cytokines and Directly Cause Bone Loss

  2015cites this paper
• Changes in bone mineral density and bone turnover markers in patients undergoing hematopoietic stem cell transplant

  2015influential citation
• Late Effects in Survivors After Hematopoietic Cell Transplantation in Childhood

  2014cites this paper
• Intermittent zoledronic Acid prevents bone loss in adults after allogeneic hematopoietic cell transplantation.

  2013cites this paper
• The role of insulin-like growth factor 1, receptor activator for nuclear factor κB ligand - osteoprotegerin system, interleukin 6 and 1β in post-transplantation bone metabolic disease in childhood.

  2013cites this paper
• Brief Report: Long‐Term Functional Engraftment of Mesenchymal Progenitor Cells in a Mouse Model of Accelerated Aging

  2013cites this paper
• 61. Transplantation Osteoporosis

  2013cites this paper
• Modifiable risk factors associated with bone deficits in childhood cancer survivors

  2012cites this paper
• Hematolojik maligniteli olgularda kök hücre transplantasyonu sonrası erken ve geç dönemde ortaya çıkan endokrinolojik komplikasyonlar

  2012cites this paper
• Hematolojik maligniteli olgularda kök hücre transplantasyonu sonrasi erken ve geç dönemde ortaya çikan endokrinolojik komplikasyonlar Early and late endocrinologic complications of the hematopoetic stem cell transplantation performed for hematologic malignancies

  2012cites this paper
• Common Genetic Variants Are Associated with Accelerated Bone Mineral Density Loss after Hematopoietic Cell Transplantation

  2011cites this paper
• Maintaining bone health in patients with multiple myeloma: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.

  2011cites this paper
• NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks.

  2011cites this paper
• Osteoporosis following organ transplantation: pathogenesis, diagnosis and management

  2011cites this paper
• Post-transplantation osteoporosis.

  2010cites this paper
• Bone markers after total body irradiation in childhood

  2010cites this paper
• Biomarkers of bone and mineral metabolism following bone marrow transplantation.

  2009cites this paper
• Low bone mineral density is associated with insulin resistance in bone marrow transplant subjects

  2009cites this paper
• Approach to the patient with transplantation-related bone loss.

  2009influential citation
• Chapter 5 Biomarkers of bone and mineral metabolism following bone marrow transplantation

  2009cites this paper
• High prevalence of early-onset osteopenia/osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy

  2008cites this paper
• Down-regulation of epidermal growth factor receptor-dependent signaling by Porphyromonas gingivalis lipopolysaccharide in life-expanded human gingival fibroblasts.

  2008cites this paper
• Osteoporosis Associated with Cancer Therapy

  2008cites this paper
• Bone loss and its management in long-term survivors from allogeneic stem cell transplantation.

  2007cites this paper
• The effects of various irradiation doses on the growth and differentiation of marrow‐derived human mesenchymal stromal cells

  2007cites this paper
• Prevention of Osteoporosis and Hypogonadism by Allogeneic Ovarian Transplantation in Conjunction With Intra-Bone Marrow–Bone Marrow Transplantation

  2007cites this paper
• Loss of bone mineral density and secondary hyperparathyroidism are complications of autologous stem cell transplantation

  2007cites this paper
• Post-transplantation osteoporosis.

  2007cites this paper
• Infantile hypophosphatasia: transplantation therapy trial using bone fragments and cultured osteoblasts.

  2007cites this paper
• REVIEW: Bone Loss and Its Management in Long-Term Survivors from Allogeneic Stem Cell Transplantation

  2007cites this paper
• Endocrine complications of hematopoietic stem cell transplantation.

  2007cites this paper
• Bone health in children and adolescents after allogeneic stem cell transplantation

  2007cites this paper
• Imbalance of the Osteoprotegerin/RANKL Ratio in Bone Marrow Microenvironment After Allogeneic Hemopoietic Stem Cell Transplantation

  2006cites this paper
• Skeletal Complications of Breast Cancer Therapies

  2006cites this paper
• Skeletal Neoplasms

  2006cites this paper
• CHAPTER 42 – Transplantation Osteoporosis: Biochemical Correlates of Pathogenesis and Treatment

  2006cites this paper
• Meeting report from skeletal complications of malignancy IV

  2006cites this paper
• Transplantation Osteoporosis: Biochemical Correlates of Pathogenesis and Treatment

  2006cites this paper
• Disorders of endocrine, reproductive and skeletal systems following allogeneic or autologous stem cell transplantation for hematological malignancies in adults

  2006cites this paper
• Bone loss and fracture risk associated with cancer therapy.

  2006cites this paper
• Effects of various antireabsorptive treatments on bone mineral density in hypogonadal young women after allogeneic stem cell transplantation

  2006cites this paper
• In vitro osteogenesis from human skin‐derived precursor cells

  2006cites this paper
• Pamidronate reduces bone loss after allogeneic stem cell transplantation.

  2006cites this paper
• Short-term zoledronic acid treatment increases bone mineral density and marrow clonogenic fibroblast progenitors after allogeneic stem cell transplantation.

  2005cites this paper
• The Changes in the Serum RANKL and OPG levels after Bone Marrow Transplantation: Association with Bone Mineral Metabolism

  2005cites this paper
• Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate.

  2005cites this paper
• Analysis of fatty acid composition in human bone marrow aspirates.

  2005cites this paper
• Prospective study of changes in bone mineral density and turnover in children after hematopoietic cell transplantation.

  2005cites this paper
• Bone disease after bone marrow transplantation

  2005cites this paper
• Serum osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) concentrations in allogeneic stem cell transplant-recipients: a role in bone loss?

  2005cites this paper
• Impact of circulating bone-resorbing cytokines on the subsequent bone loss following bone marrow transplantation

  2004cites this paper
• Osteoblast and Osteoclast Activity in a Malignant Infantile Osteopetrosis Patient Following Bone Marrow Transplantation

  2004cites this paper
• Replacement of recipient stromal/mesenchymal cells after bone marrow transplantation using bone fragments and cultured osteoblast-like cells.

  2004cites this paper
• Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: impact on bone and mineral metabolism.

  2004cites this paper
• Management of Bone Loss After Organ Transplantation

  2004cites this paper
• Osteoporosis after solid organ and bone marrow transplantation

  2003influential citation
• Endocrine late effects of cancer treatment

  2003cites this paper
• Bone mineral density in pediatric transplant recipients1

  2003cites this paper
• Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies

  2003cites this paper
• Bone mineral density in pediatric transplant recipients.

  2003cites this paper
• FEATURED CME TOPIC: OSTEOPOROSIS

  2002cites this paper
• The skeletal site-differential changes in bone mineral density following bone marrow transplantation: 3-year prospective study.

  2002cites this paper
• Long-lasting bone damage detected by dual-energy x-ray absorptiometry, phalangeal osteosonogrammetry, and in vitro growth of marrow stromal cells after allogeneic stem cell transplantation.

  2002cites this paper